2'3'-didehydro-2'3'-dideoxyadenosine has been researched along with zalcitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Balzarini, J; Broder, S; De Clercq, E; Herdewijn, P; Pauwels, R; Vanderhaeghe, H | 1 |
| Gangadhara, KL; Herdewijn, P; Lescrinier, E; Pannecouque, C | 1 |
2 other study(ies) available for 2'3'-didehydro-2'3'-dideoxyadenosine and zalcitabine
| Article | Year |
|---|---|
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents.
Topics: Antiviral Agents; Cell Line; Chemical Phenomena; Chemistry; Cytopathogenic Effect, Viral; Deoxyribonucleosides; HIV; Humans; Structure-Activity Relationship; T-Lymphocytes; Virus Replication | 1987 |
Hydroxy fatty acids for the delivery of dideoxynucleosides as anti-HIV agents.
Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Dideoxynucleosides; Drug Delivery Systems; Fatty Acids; HIV-1; Humans; Hydroxy Acids; Molecular Structure; Prodrugs | 2014 |